InsiderClue
Stocks · Health care · Pharmaceutical Preparations

BioAge Labs, Inc.

BIOA Clue Score39
United States Fiscal year ends December CIK 0001709941 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Scheduled selling only

Individual transactions

12
Insider
Date
Role
Action
Shares
Price
Amount
Shane Barton
30 Jun 2026
Principal Accounting Officer
Sold after exercise
20,216
$25.19
$509.18K
Shane Barton
29 Jun 2026
Principal Accounting Officer
Sold after exercise
42,350
$25.21
$1.07M
Paul D Rubin
1 Apr 2026
Chief Medical Officer
Sold after exercise
8,820
$17.81
$157.08K
Paul D Rubin
2 Mar 2026
Chief Medical Officer
Sold after exercise
7,433
$20.30
$150.89K
Paul D Rubin
2 Feb 2026
Chief Medical Officer
Sold after exercise
7,433
$18.75
$139.37K
Dov A Md Goldstein
13 Jan 2026
Chief Financial Officer
Sold after exercise
1,923
$21.08
$40.54K
Dov A Md Goldstein
13 Jan 2026
Chief Financial Officer
Sold after exercise
11,663
$20.54
$239.55K
Dov A Md Goldstein
13 Jan 2026
Chief Financial Officer
Sold after exercise
4,440
$19.45
$86.37K
Dov A Md Goldstein
13 Jan 2026
Chief Financial Officer
Sold after exercise
8,974
$18.43
$165.37K
Paul D Rubin
2 Jan 2026
Chief Medical Officer
Sold after exercise
7,433
$12.85
$95.49K
Paul D Rubin
9 Dec 2025
Chief Medical Officer
Sold after exercise
18,000
$12.00
$216.00K
Paul D Rubin
4 Dec 2025
Chief Medical Officer
Sold after exercise
68,897
$10.19
$701.91K
Show all 17 transactions →

What was left out

Form 4 filings counted 24
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 12
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 219,117
History held since 27 Sep 2024